Deal Library / Pharma BD Deal Intelligence

Novartis — Pharma Deals

The Pharma Closeout tracks 15 deals, $3.0B in disclosed deal value, 1 with a post-close Outcome Score for Novartis.

Median Outcome Score: 68

All 15 deals

• Novartis / Arvinas, Inc. — 2024 · $1.2B · Largely worked — most objectives met.
• Novartis / Matchpoint — 2025 · $1.0B
• Novartis / Isomorphic Labs — 2024
• Novartis / Vyriad — 2024
• Novartis / Schrödinger — 2024
• Novartis / IFM Due — 2024 · $835M
• Novartis / BioAge Labs — 2024
• Novartis / Ratio Therapeutics — 2024
• Novartis / Deciphex — 2024
• Novartis / SanReno Therapeutics — 2024
• Novartis / Artios Pharma Limited — 2021
• Novartis / Bristol Myers Squibb — 2017
• Novartis / Surface Oncology — 2016
• Novartis / Conatus Pharmaceuticals — 2016
• Novartis / Xencor — 2016

← Deal Library  ·  Interactive search  ·  How we score deals